Assertio Therapeutics, Inc.

IL · United States · Reporting entity ID 100000000324

Total reported 2019–2025

$834K

#1,383 of 2,960 reporting companies — 0% of all reported industry payments

$278K in general payments across 11,459 records, plus $556K in research funding across 9 records.

How it breaks down

General payments $277,825

Research funding $556,294

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.